KYLYS AESTHETICS offers a biocompatible hyaluronan-based and thermosensitive dermal filler that has the ability to form microgel structures in the tissue, resulting in a long-lasting effect and no migration from the injection site. Our patented technology allows for injection with an ultra-thin 34G needle, 80% thinner than those used by market alternative, resulting in greater precision, less pain for the patient, and fewer hematomas. With our cutting-edge technology and commitment to research and development, we aim to revolutionize the market of skin filling.
We recently completed all preclinical testing, including biocompatibility, and are now preparing for our 1st pilot clinical trial.
We recently completed all preclinical testing, including biocompatibility, and are now preparing for our 1st pilot clinical trial.